Exacerbations de bronchite chronique

Medecine et Maladies Infectieuses

Volumn 31, Issue SUPPL.4, 2001, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4243569271     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. Agence du Médicament. Recommandation. Méd Mal Infect 1999 ; 29(4) : 209-11.
2. Chauvin P, Petitpretz P, Brai A, Fournier M, Flahault A, Neukirch F, Valleron AJ. Prise en charge des épisodes infectieux bronchiques en médecine générale. Rev Mal Respir 1996 ; 13 : 397-404.
3. Kesten S, Chapman KR. Physician perceptions and management of COPD: Special Report. Chest 1993 ; 104 : 254-8.
4. Sachs APE, Koëter GH, Groeneir KH, Van der Waaij D, Schiphuis J, Meyboom-de-Jong B. Changes in symptoms, peak expiratory flow and sputum flora during treatment with antibiotics of exacerbations in patients with COPD in general practice. Thorax 1995 ; 50 : 758-63.
5. Smith JA, Redman P, Woodhead M. Antibiotic use in patients admitted with acute axacerbations of chronic obstructive pulmonary disease. Eur Respir J 1999 ; 13 : 835-8.
6. Taytard A, Vernejoul JM, Villanueva P, Tunon de Lara JM. Stratégies diagnostiques et thérapeutiques devant les surinfections de bronchite chronique en pratique de ville. Rev Mal Respir 1995 ; 12 : 371-6.
7. Trévisani L. Antibiotics in acute bronchitis and exacerbations of chronic bronchitis: what is general practitioner's habit? Chest 1997; 111 : 1788-9.
8. Destache CJ, Dewan N, O'Donohue WJ, Clayton Campbell J, Angellino VA. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1999 ; 43(Suppl A) : S107-13.
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (copd) and asthma. Am Rev Respir Dis 1987 ; 136 : 225-44.
10. Belleguic C, Lena H, Renaud JC, Desrues B, Delaval P. Bronchectasies. Encycl Méd Chir. Pneumologie, 6-031-A-10, 2000, 6 p.
11. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purpose. Lancet 1965 ; 1 : 775-9.
12. Similowski Th, Muir JF, Derenne JP. In : Les bronchopneumopathies chroniques obstructives. Editions John Libbey Eurotext, 1999.
13. Teculescu D. Définitions claires des bronchopneumopathies chroniques : un impératif pour la pratique pneumologique, l'enseignement et la recherche. Rev Pneumol Clin 1990 ; 46 : 194-9.
14. Ball P, Harris JM, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. Q J Med 1995 ; 88 : 61-8.
15. Mayaud C, Trémolières F et le groupe de Travail de la SPILF. Recommandations pour la prise en charge anti-infectieuse des exacerbations de bronchite chronique. Med Mal Infect 1996 ; 26 : 344-7.
16. Eller J, Ede A, Schaberg T, Niederman M, Mauch H, Lode H. Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function. Chest 1998 ; 113 : 1542-8.
17. Grossman RF. The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. Chest 1998; 113 : 249S-55S.
18. Ball P, Barry M. Acute exacerbations of chronic bronchitis: An international comparison. Chest 1998 ; 113 : 199S-204S.
19. Carilli CA, Gohd RS, Gordon W. A virologic study of chronic bronchitis. N Engl J Med 1964 ; 16 : 123-7.
20. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987 ; 106 : 196-204.
21. Soyka LF, Robinson DS, Lachant N, Monaco J. The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics 1975 ; 55 : 552-6.
22. Chodosh S. Treatment of acute exacerbation of chronic bronchitis: State of the art. Am J Med 1991 ; 91 : 87S-92S.
23. Paterson IC, Petrie GR, Crompton GK. Chronic bronchitis: is bacteriological examination of sputum necessary? Br Med J 1978 : 537-8.
24. Société de Pneumologie de Langue Française (SPLF). Recommandations pour la prise en charge des bronchopneumopathies chroniques obstructives. Rev Mal Resp 1997 ; 14 : 2S66-76.
25. Musher DM, Kubitschek KR, Crennan J, Baughn RE. Pneumoniae and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983 ; 99 : 444-50.
26. Isada CM. Pro: Antibiotics for chronic bronchitis with exacerbations. Seminars in Respiratory Infections 1993 ; 8 : 243-53.
27. Monso E, Ruiz J, Rossell A, Manterola J, Fiz, Morera J, Ausina V. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995 ; 152 : 1316-20.
28. Philit F, Etienne J, Calvet A, Mornex JF, Trillet V, Aymard M, Brune J, Cordier JF. Agents infectieux associés aux décompensations des bronchopathies chroniques obstructives et aux attaques d'asthme. Rev Mal Respir 1992 ; 9 : 191-6.
29. Fisher M, Akhtar AJ, Calder MA, Moffat MAJ, Stewart SM, Zealley H, Crofton JW. Pilot study of factors associated with exacerbations in chronic bronchitis. Br Med J 1969 ; 4 : 187-92.
30. Eadie MB, Stott EJ, Grist NR. Virological studies in chronic bronchitis. Br Med J 1966 ; 2 : 671-3.
31. Murphy TF, Sethi S. State of the art: Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992 ; 146 : 1067-83.
32. McHardy VU, Inglis J, Calder MA, Crofton JW, Gregg I, Ryland DA, Taylord P, Chadwick M, Coombs D, Riddell W. A study of infective and other factors in exacerbations of chronic bronchitis. Br J Dis Chest 1980 ; 74 : 228-38.
33. Fagon J-Y, Chastre J, Trouillet JL, Domart Y, Dombret MC, Bornet M, Gibert Cl. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990 ; 142 : 1004-8.
34. Anzueto A, Niederman MS, Tillotson GS and the Bronchitis Study Group. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg bid versus clarithromycin 500 mg bid. Clin Therap 1998 ; 20 : 885-900.
35. Gump DW, Phillips CA, Forsyth BR, McIntosh K, Lamborn KR, Stouch WH. Role of infection in chonic bronchitis. Am Rev Respir Dis 1976; 113 : 465-74.
36. Buscho RO, Saxtan D, Shultz PS, Finch E, Mufson MA. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978 ; 137 : 377-85.
37. Smith CB, Golden CA, Kanner RE, Renzetti AD. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illnes in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980 ; 121 : 225-32.
38. McNamara MJ, Phillips IA, Williams OB. Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. Am Rev Respir Dis 1969 ; 100 : 19-24.
39. Connors AF, Dawson NV, Thomas C, Harrel FE, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996 ; 154 : 959-67.
40. Fuso L, Incalzi RA, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, Gliozzi F, Ciappi G. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995 ; 98 : 272-7.
41. Vereen L, Smart LM, George RB. Antibody coating and quantitatives cultures of bacterial in sputum and bronchial brush specimens from patients with stable chronic bronchitis. Chest 1986 ; 90 : 534-6.
42. Medici TC, Chodosh S. The reticuloendothelial system in chronic bronchitis: Quantitative sputum cell populations during stable, acute bacterial infection, and recovery phases. Am Rev Respir Dis 1972 ; 105 : 792-804.
43. Baigelman W, Chodosh S, Pizzuto D, Sadow T. Quantitative sputum gram stains in chronic bronchial disease. Lung 1979 ; 156 : 265-70.
44. Clancy Rl, Murree-Allen K, Cripps A, Yeung S, Engel M. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet 1985; 2 : 1395-7.
45. Clancy J, Cripps AW. Specific protection against bronchitis associated with nontypable Haemophilus influenzae. J Infect Dis 1992 ; 165(Suppl 1) : S194-5.
46. Lehmann D, Coakley KJ, Coakley CA, Spooner V, Montgomery JM, Michael A, Riley ID, Smith T, Clancy RL, Cripps AW, Alpers MP. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the Highlands of Papua New Guinea. Am Rev Respir Dis 1991 ; 144 : 324-30.
47. Dev D, Wallace E, Sankaran R, Cunniffe J, Govan JRW, Wathen CG, Emmanuel FXS. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med 1998 ; 92(4) : 664-7.
48. Blasi F, Legnani D, Lombardo VM, Negretto GG, Magliano, Pozzoli R, Chiodo F, Fasoli A, Allegra L. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993 ; 6 : 19-22.
49. Beaty CD, Grayston JT, Wang S-P, Kuo C-C, Reto CS, Martin TR. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991 ; 144 : 1408-10.
50. Westenberg SC, Smith Ch, Renzetti AD. Mycoplasma infections in patients with chronic obstructive pulmonary disease. J Infect Dis 1973 ; 127 : 491-7.
51. Freymuth F, Petitjean J, Eugène G, Vabret A. Infection bronchique et virus. In : L'infection bronchique en questions ; Groupe ECRIR, Institut Maurice Rapin. Médecine Sciences Flammarion, Paris 1997 : 29-33.
52. Smith CB, Golden C, Klauber MR, Kanner R, Renzetti A. Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976 ; 134 : 552-61.
53. Canadian Thoracic Society Workshop Group. Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 1992 ; 147 : 420-8.
54. Stockley RA, Burnett D. Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection. Bull Eur Physiopath Respir 1980 ; 16 : 261-71.
55. Madison JM, Irwin RS. Chronic obstructive pulmonary disease. Lancet 1998 ; 352 : 467-73.
56. Nicotra MB, Kronenberg RS. Con: Antibiotic use in exacerbations of chronic bronchitis. Seminars in Respiratory Infections 1993 ; 8 : 254-8.
57. Bryant RE, Rhoades E. Clinical features of adenoviral pneumoniae in air force recruits. Am Rev Respir Dis 1967 ; 96 : 717-23.
58. Pines A, Raafat H, Plucinski K, Greenfield JSB, Solari M. Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis. Br Med J 1968 ; 2 : 735-8.
59. Pines A, Raafat H, Plucinski K, Greenfield JSB, Linsell WD, Solari M. Antibiotic regimens in moderately ill patients purulent exacerbations of chronic bronchitis. Br J Dis Chest 1972 ; 66 : 107-15.
60. Elmes P, Fletcher C, Dutton A. Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis. Br Med J 1957 ; 2 : 1272-5.
61. Berry DG, Fry J, Hindley CP, Hodson JM, Horder EJ, Horder JP, Marien EAW, Rea JN, Ryle A, Curven MP, Tomlinson AJH. Exacerbations of chronic bronchitis treatment with oxytetracycline. Lancet 1960 ; 1 : 137-9.
62. Fear E, Edwards G. Antibiotic regimes in chronic bronchitis. Br J Dis Chest 1962 ; 56 : 153-62.
63. Elmes P, King TKD, Langlands JHM, Mackay JA, Wallace WFM, Wade OL, Wilson TS. Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis. Br Med J 1965 ; 2 : 904-8.
64. Petersen ES. A controlled study of the effect of treament on chronic bronchitis. An evaluation using pulmonary function tests. Acta Medica Scand 1967 ; 182 : 293-305.
65. Nicotra M, Rivera M, Awe RJ. Antibiotic therapy of acute exacerbations of chronic bronchitis. Ann Intern Med 1982 ; 97 : 18-21.
66. Jorgensen AF, Coolidge JO, Pedersen A, Pfeiffer Pettersen K, Waldorff S, Widding E. Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo-controlled multicentre study in general practice. Scand J Prim Health Care 1992 ; 10 : 7-11.
67. Manresa F, Blavia R, Martin R, Linares J, Rodrigues B, Verdaguer R. Antibiotics for exacerbations of chronic bronchitis. Lancet 1987; 15 : 394-5.
68. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 1995 ; 273(12) : 957-60.
69. Hasani A, Pavia D, Rotondetto S, Clarke SW, Spiteri, Agnew JE. Effect of oral antibiotics on lung mucociliary clearance during exacerbation of chronic obstructive pulmonary disease. Respir Med 1998 ; 92 : 442-7.
70. Derenne JP, Fleury B, Pariente R. Acute respiratory failure of COPD. Am Rev Respir Dis 1988 ; 138 : 1006-33.
71. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumoniae. A prospective study of a general population. Eur Respir J 1995 ; 8 : 1694-8.
72. Lode H. Respiratory tract infections: When is antibiotic therapy indicated? Clinical Therapeutics 1991 ; 13 : 149-56.
73. Doring G, Albus A, Hoiby N. Immunologic aspects of cystic fibrosis. Chest 1988 ; 94 : 109S-15S.
74. Bates D. The fate of the chronic bronchitic: a report of a 10 year follow-up in the Canadian department of Veteran's affairs coordinated study of chronic bronchitis. Am Rev Respir Dis 1973 ; 108 : 1043-5.
75. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977 ; 1 : 1645-8.
76. Howard P. A long term follow up of respiratory symptoms and ventilatory function in a group of working men. Br J Industr Med 1970 ; 27 : 326-33.
77. Kanner R, Renzetti AD, Klauber MR, Smith CB, Golden CA. Variables associated with changes in spirometry in patients with obstructive lung diseases. Am J Med 1979 ; 67 : 44-50.
78. Cole P. Host-microbe relationships in chronic respiratory infection. Respiration 1989 ; 55 : S5-8.
79. e édition. OVP Editions du Vidal, Paris.
80. Bierman C, Loken A, Ruse R. Comparison of spiramycin and doxycycline in the treatment of lower respiratory infections in general practice. J Antimicrob Chemother 1988 ; 22(Suppl B) : S155-8.
81. Punakivi L, Keistinen T, Backman R, Lehtipuu A-L, Saarelainen P, Vilkka V, Veneskoski T, Ammälä K, Aro A. Oral ofloxacin once daily and doxycycline in the treatment of acute exacerbations of chronic bronchitis. Scand J Infect Dis 1990 ; 68(Suppl) : S41-5.
82. Periti P, Novelli A, Schildwachter G, Schmidt-Gayk H, Ryo Y, Zuck P. Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. J Antimicrob Chemother 1990 ; 26(Suppl E) : S63-9.
83. Mertens JCC, Van Barneveld PWC, Aisn HRG, Ligtvoet E, Visser MR, Branger T, Hoepelman AIM. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. Antimicrob Agents Chemother 1992 ; 36 : 1456-9.
84. Gaillat J. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis. J Antimicrob Chemother 1993 ; 31(Suppl C) : S139-51.
85. Phillips H, Van Hook CJ, Butler T, Todd WM. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults. Chest 1993 ; 104 : 1387-92.
86. Hoepelman IM, Möllers MJ, van Schie MH, Greefhorst AMP, Schlösser NJJ, Sinninghe Damsté EJ, van de Moosdijk CNF, Dalinghaus WH, Eland ME, Mol SJM, Rosenberg-Arska M. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome. Int J Antimicrob Agents 1998 ; 9 : 141-6.
87. Aubier MA. Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. Chemotherapy 1997 ; 43(4) : 297-302.
88. Chodosh S, Lakshminarayan S, Swarz H, Breisch S. Efficacy and safety of 10 day course of 400 or 600 mg of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10 day course of 500 mg of ciprofloxacin twice daily. Antimicrob Agents Chemother 1998 ; 42 : 114-20.
89. Chodosh S, Schreurs Ad, Siami G, Barkman W, Anzuetto A, Shan M, Moesker H, Stack T, Kowalsky S, the Bronchitis Study Group Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clin Infect Dis 1998 ; 27(4) : 730-8.
90. Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S, the Bronchitis Study Group. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. Clin Infect Dis 1998 ; 27(4) : 722-9.
91. Langan CE, Cranfield R, Breisch S, Pettit R. Randomised, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother 1997 ; 40 : 63-72.
92. McAdoo MA, Rice K, Gordon GR, Sahn SA. Comparaison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis. Clin Therap 1998 ; 20 : 88.
93. DeAbate CA, Myers D, Henry D, Upchurch J, Lecara G, Giguere G, Collins JJ. Efficacy and tolerability of once daily grepafloxacin compared with clarithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis. Clin Drug Invest 1999; 17 : 21-31.
94. Lorenz J. Comparaison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis. Chemotherapy 1998; 44 : S15-8.
95. Rodnick JE, Gude JK. The use of antibiotics in acute bronchitis and acute exacerbations of chronic bronchitis. West J Med 1988 ; 149 : 347-51.
96. Société de Pathologie Infectieuse de Langue Française (SPILF). Les infections des voies respiratoires : 4e Conférence de Consensus en Thérapeutique Anti-infectieuse (Lille 1990). Med Mal Infect 1991 ; 21 : S3-8.
97. Balter MS, Hyland RH, Lowde, et al. Recommandations on the management of chronic bronchitis. Can Med Assoc J 1994 ; 151 : S1-23.
98. Siafakas NM, Vermeire P, Pride NB, et al. ERS Consensus statement. Optimal assessment and managment of COPD. Eur Respir J 1995 ; 8 : 1398-420.
99. British Thoracic Society. COPD Guidelines. Thorax 1997 ; 52 : S4-28.
100. Société de Pneumologie de Langue Française (SPLF). Recommandations pour la prise en charge des bronchopneumopathies chroniques obstructives : Traitement antibiotique des exacerbations des BPCO. Rev Mal Respir 1997 ; 14 : 2S23-5.
101. Huchon G, Chidiac C, Delaval P, Léophonte P, Mouton Y, Roche N, Trémolières F. Recommandations de la SPLF : Conduite à tenir devant une infection respiratoire basse communautaire de l'adulte. Rev Mal Respir 1999 ; 16 : 224-33.
102. Agence du Médicament. Broncho-pneumopathie chronique obstructive (BPCO). Fiches de transparence 1999 : 251-5.
103. Ross GM, Croydon EAP. A winter-long trial of ampicillin in chronic bronchitis. Br J Dis Chest 1973 ; 67 : 153-60.
104. Bennet JB, Crook SJ, Shaw EJ, Davies RJ. A randomized double blind controlled trial comparing two amoxycillin regimens in the treatment of exacerbations of chronic bronchitis. J Antimicrob Chemother 1988 ; 21 : 225-32.
105. DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. Clin Therap 1999; 21 : 172-88.